Cargando…

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study

BACKGROUND: This study explored the rationality of the 2018 International Federation of Gynecology and Obstetrics (FIGO) stage IIIC for cervical cancer to determine outcomes. METHODS: We conducted a retrospective study of cervical cancer patients who had received radical surgery or Radiotherapy. Mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhiqiang, Duan, Hui, Guo, Jianxin, Yang, Ying, Wang, Wuliang, Hao, Min, Li, Weili, Li, Pengfei, Bin, Xiaonong, Lang, Jinghe, Liu, Ping, Chen, Chunlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article on New Progress and Challenge in Gynecological Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848354/ https://www.ncbi.nlm.nih.gov/pubmed/35282078 http://dx.doi.org/10.21037/atm-21-6374

Ejemplares similares

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study
por: Ye, Yanna, et al.
Publicado: (2023)

Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study
por: Li, Pengfei, et al.
Publicado: (2022)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

New progress and challenge in gynecological cancer
por: Wang, Danbo
Publicado: (2022)

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study
por: Wang, Huimin, et al.
Publicado: (2022)

Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression
por: Li, Jian, et al.
Publicado: (2022)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients
por: Chen, Jian, et al.
Publicado: (2021)

Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer
por: Yang, Xiaocheng, et al.
Publicado: (2022)

Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer
por: Liu, Qingyang, et al.
Publicado: (2022)

Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival
por: Yang, Jie, et al.
Publicado: (2022)

Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer
por: Liu, Liying, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility‐Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer
por: Zusterzeel, Petra L.M., et al.
Publicado: (2020)

Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer
por: Chen, Chunlin, et al.
Publicado: (2019)

Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort
por: Vengaloor Thomas, Toms, et al.
Publicado: (2021)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
por: Kagabu, Masahiro, et al.
Publicado: (2021)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2012)

Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis
por: Li, Weili, et al.
Publicado: (2021)

A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis
por: Meng, Qingyu, et al.
Publicado: (2023)

Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
por: Aigner, Karl R., et al.
Publicado: (2021)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
por: Chao, Xiaopei, et al.
Publicado: (2022)

The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer
por: Low, Jia Li, et al.
Publicado: (2019)

Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies
por: Zhao, Dong, et al.
Publicado: (2023)

The Effect of Laparoscopic Radical Hysterectomy Surgical Volume on Oncology Outcomes in Early-Stage Cervical Cancer
por: Li, Pengfei, et al.
Publicado: (2021)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Pretreatment [(18)F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1
por: Burchardt, Ewa, et al.
Publicado: (2021)

Unremitting Suicidality in Borderline Personality Disorder: A Single Case Study and Discussion of Technology in Clinical Care
por: Choi-Kain, Lois W., et al.
Publicado: (2022)

Patterns of Care and Outcomes for Small Cell Carcinoma of the Cervix: A National Retrospective Analysis of 542 Cases
por: Wharton, David, et al.
Publicado: (2019)

The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer
por: Song, Jiheon, et al.
Publicado: (2020)

A combined clinical and genetic model for predicting risk of ovarian cancer
por: Dite, Gillian S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhbqdurr1qlpio5ap1uicqpplf